| Product Code: ETC7731438 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Antimicrobial Resistance Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Antimicrobial Resistance Market - Industry Life Cycle |
3.4 Japan Antimicrobial Resistance Market - Porter's Five Forces |
3.5 Japan Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Japan Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Japan Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 Japan Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
4 Japan Antimicrobial Resistance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of antimicrobial resistance in Japan |
4.2.2 Growing awareness among healthcare professionals and patients about the threat of antimicrobial resistance |
4.2.3 Government initiatives to combat antimicrobial resistance through regulations and policies |
4.3 Market Restraints |
4.3.1 Limited availability of effective antibiotics to combat resistant strains |
4.3.2 High costs associated with developing new antimicrobial drugs |
4.3.3 Lack of incentives for pharmaceutical companies to invest in research and development of new antibiotics |
5 Japan Antimicrobial Resistance Market Trends |
6 Japan Antimicrobial Resistance Market, By Types |
6.1 Japan Antimicrobial Resistance Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Japan Antimicrobial Resistance Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Japan Antimicrobial Resistance Market Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021- 2031F |
6.1.4 Japan Antimicrobial Resistance Market Revenues & Volume, By Blood stream infections, 2021- 2031F |
6.1.5 Japan Antimicrobial Resistance Market Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021- 2031F |
6.1.6 Japan Antimicrobial Resistance Market Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021- 2031F |
6.1.7 Japan Antimicrobial Resistance Market Revenues & Volume, By Community acquired pneumonia (CAP), 2021- 2031F |
6.1.8 Japan Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Japan Antimicrobial Resistance Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Japan Antimicrobial Resistance Market Revenues & Volume, By Combination therapies, 2021- 2031F |
6.2.3 Japan Antimicrobial Resistance Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.2.4 Japan Antimicrobial Resistance Market Revenues & Volume, By Cephalosporins, 2021- 2031F |
6.2.5 Japan Antimicrobial Resistance Market Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021- 2031F |
6.2.6 Japan Antimicrobial Resistance Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.2.7 Japan Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Japan Antimicrobial Resistance Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 Japan Antimicrobial Resistance Market Revenues & Volume, By Protein Synthesis Inhibitors, 2021- 2031F |
6.3.3 Japan Antimicrobial Resistance Market Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021- 2031F |
6.3.4 Japan Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Japan Antimicrobial Resistance Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 Japan Antimicrobial Resistance Market Revenues & Volume, By Klebsiella pneumoniae, 2021- 2031F |
6.4.3 Japan Antimicrobial Resistance Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.4.4 Japan Antimicrobial Resistance Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.4.5 Japan Antimicrobial Resistance Market Revenues & Volume, By Enterococcus Spp, 2021- 2031F |
6.4.6 Japan Antimicrobial Resistance Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.4.7 Japan Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
7 Japan Antimicrobial Resistance Market Import-Export Trade Statistics |
7.1 Japan Antimicrobial Resistance Market Export to Major Countries |
7.2 Japan Antimicrobial Resistance Market Imports from Major Countries |
8 Japan Antimicrobial Resistance Market Key Performance Indicators |
8.1 Percentage increase in the adoption of antimicrobial stewardship programs in healthcare facilities |
8.2 Reduction in the incidence of healthcare-associated infections caused by multidrug-resistant organisms |
8.3 Number of research grants and funding allocated to antimicrobial resistance research |
9 Japan Antimicrobial Resistance Market - Opportunity Assessment |
9.1 Japan Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Japan Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Japan Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 Japan Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
10 Japan Antimicrobial Resistance Market - Competitive Landscape |
10.1 Japan Antimicrobial Resistance Market Revenue Share, By Companies, 2024 |
10.2 Japan Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here